Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women

Ather Mansoor1, Keri Althoff, Stephen Gange

  • 1Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA.

Insights

HIV infection is linked to higher natriuretic peptide levels, but this is primarily due to co-existing conditions like anemia and kidney disease, not the virus itself. These peptides signal overall comorbidity in HIV-infected individuals.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Nephrology

Background:

  • HIV infection is associated with left ventricular dysfunction and accelerated atherosclerosis, leading to elevated plasma natriuretic peptide (NP) levels.
  • Natriuretic peptides, such as N-terminal-pro-BNP (NT-pro-BNP), are biomarkers of cardiac stress and dysfunction.

Purpose of the Study:

  • To compare NT-pro-BNP levels in HIV-infected and HIV-uninfected women.
  • To identify factors influencing NT-pro-BNP levels in HIV-infected women.

Main Methods:

  • A cross-sectional study involving 454 HIV-infected and 200 HIV-uninfected women from the Women's Interagency HIV Study (WIHS).
  • NT-pro-BNP levels were measured and compared using age-stratified cut-off values.
  • Statistical analyses, including univariate and multivariate models, were used to identify associated factors.

Main Results:

  • HIV-infected women had significantly higher NT-pro-BNP levels and a higher prevalence of elevated levels compared to HIV-uninfected women.
  • Elevated NT-pro-BNP was significantly associated with anemia, kidney dysfunction, and Hepatitis C Virus (HCV) seropositivity in multivariate analysis.
  • In HIV-infected women, NT-pro-BNP levels were not independently associated with HIV severity or HAART use.

Conclusions:

  • Elevated NT-pro-BNP levels in HIV-infected women are primarily driven by non-HIV-related comorbidities such as anemia, kidney disease, and HCV coinfection.
  • NT-pro-BNP serves as a global marker of comorbidity in the context of HIV infection.
  • These findings underscore the importance of managing comorbidities in HIV-infected individuals to improve cardiovascular outcomes.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...